Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27751846

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Dec
First author
Mir O

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Dec;17(12):1633-1634. doi: 10.1016/S1470-2045(16)30509-5.
    note
    Source null
    related pmid
    27751848
    relationship
    Comment in

Authors and identifiers

  1. name
    Mir O
    type
    Author
  2. name
    Brodowicz T
    type
    Author
  3. name
    Italiano A
    type
    Author
  4. name
    Wallet J
    type
    Author
  5. name
    Blay JY
    type
    Author
  6. name
    Bertucci F
    type
    Author
  7. name
    Chevreau C
    type
    Author
  8. name
    Piperno-Neumann S
    type
    Author
  9. name
    Bompas E
    type
    Author
  10. name
    Salas S
    type
    Author
  11. name
    Perrin C
    type
    Author
  12. name
    Delcambre C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mir O
    type
    Author
  2. name
    Brodowicz T
    type
    Author
  3. name
    Italiano A
    type
    Author
  4. name
    Wallet J
    type
    Author
  5. name
    Blay JY
    type
    Author
  6. name
    Bertucci F
    type
    Author
  7. name
    Chevreau C
    type
    Author
  8. name
    Piperno-Neumann S
    type
    Author
  9. name
    Bompas E
    type
    Author
  10. name
    Salas S
    type
    Author
  11. name
    Perrin C
    type
    Author
  12. name
    Delcambre C
    type
    Author
bibliography ids
  1. nci-bib-462576570525fc74369c679d
book metadata
content sha256
2aaa9f7b21cab1dcb4ec432092fc5b8a0f9eaaa0f076342c0926144439318a6b
document type
citation
dois
  1. 10.1016/S1470-2045(16)30507-1
electronic publication date
display
2016 Oct 14
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27751846
immutable id
pubmed:27751846@2aaa9f7b21cab1dcb4ec432092fc5b8a0f9eaaa0f076342c0926144439318a6b
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
12
name
The Lancet. Oncology
nlm unique id
100957246
pages
1732-1742
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Dec;17(12):1633-1634. doi: 10.1016/S1470-2045(16)30509-5.
    note
    Source null
    related pmid
    27751848
    relationship
    Comment in
outcomes validated
false
pmid
27751846
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
c66f5291fc202470c9e269d1e289a8f93dde3d2cfadc9ef5fd7d8ef13a4e09a2
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Dec
precision
month
year
2016
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27751846/
title
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.

Preserved source evidence · Not medical advice